Radionuclide theranostics is transforming oncology by enabling more personalised treatment based on tumour biology. The ...

For 70 years, corticosteroids have been the default treatment for sarcoidosis.1 Although the field has repeatedly tried to ...

The treatment landscape of EGFR-mutated non-small-cell lung cancer harbouring exon 19 deletion or L858R mutations has ...

It was a 2015 Editorial in The Lancet Oncology discussing cancer in the transgender community, that set Alison Berner (Queen ...

Joanne Tinker remembers searching online for what a mastectomy would look like, convinced she was about to be mutilated. She ...

The introduction of thalidomide and its derivatives—lenalidomide, followed by pomalidomide—has improved the therapeutic ...

Sickle cell disease is the most common haemoglobinopathy, affecting more than 7 million people worldwide.1 Despite ...

Every year, pivotal clinical trials are reported, showing major advances in cancer treatment. At the American Society of ...

Africa’s digital health revolution, marked by a rapid increase in the number of technologies and providers of electronic health records, mobile health applications, disease surveillance platforms, and ...

Although climate change represents one of the greatest public health challenges of our time, its impacts on patients with ...

The benefit of exercise alongside cancer treatment and recovery has primarily rested on association. However, two randomised ...

Cancer experts fear a rise in cancer cases in Russia if a draft 2027 budget proposing a sharp cut of more than 90% in federal cancer funding is pushed through parliament.